There are more than 100 known species of Erythrina in the tropics. From those, approximately half have been studied.1) Erythrina plants are known to produce alkaloids, flavonoids, and terpenes.1-3) Several species of Erythrina are used in folk medicine due to their tranquilizer effects.4) Alkaloid fractions from Erythrina americana have been shown to possess anticonvulsant, hypotensive, hypnotic, and analgesic effects.5) The tranquilizer effects of crude alkaloid fractions from Erythrina americana were investigated in a model that provokes aggressiveness by visual isolation.4) The alkaloids diminished aggressive behavior in a way similar to the benzodiazepine (BZD) diazepam (DZP), used as a control. Potential therapeutic activity has also been reported for other species of Erythrina. Thus antiviral and antibacterial activity has been shown for Erythrina glauca 3) and Erythrina lysistemon 6) and analgesic and antiinflammatory effects were reported for an aqueous extract from Erythrina senegalensis.
7)Erythrina mulungu (EM) (Leguminosae-Papilionaceae), popularly known as mulungu, is a medium-sized wellbranched tree native to Southern Brazil.8) It produces a profusion of reddish flowers at the end of its branches. Since its flowers are the same color as coral, the plant is sometimes also called "coral tree." In herbal medicine, a leaf or bark decoction or tincture from mulungu is considered to calm agitation and other disorders of the nervous system, including insomnia and depression. 9) As with other species of Erythrina, alkaloids appear to be one of the main constituents of EM.
2)Recently, the supposed therapeutic properties of EM have begun to be evaluated in preclinical studies. Thus, in a previous study performed in our laboratory, 10) the effects of acute treatment with a water-alcohol extract from the inflorescence of EM were investigated in rats submitted to models specifically related to different types of anxiety disorder: the elevated T-maze (ETM), the light/dark transition, and the cat odor test. Results showed that acute treatment with EM altered both inhibitory avoidance latencies in the ETM and the behavior of rats in the light/dark transition model, in a way similar to DZP. Since previous pharmacologic studies pointed to a relationship between these two anxiety-related tasks and generalized anxiety disorder in humans, [11][12][13][14][15][16] these results suggest that acute administration of EM exerts anxiolytic-like effects in a specific subset of defensive behaviors, particularly those related to generalized anxiety.Taking the above evidence into account, the purpose of the present study was to extend the investigation of the anxiolytic potential of EM. It is important to emphasize that in the clinical setting antidepressant compounds have shown therapeutic efficacy in some subtypes of anxiety disorder, i.e., panic, only after chronic treatment.17) Since, aside from its tranquilizer effect, EM has also been popularly used to treat depression, in the present study the effects of repeated administ...